We are international
publications TEXT SIZE   

October 2003 Volume 5, Issue 8:
Early studies indicate targeted radioactive drug may expand treatment options for myeloma
By Gregory Wiseman, M.D.
Angela Dispenzieri, M.D.
The studies involve the drug Quadramet, one of a new class of drugs that target radiation directly to bone and spare the rest of the body from exposure.

Be the first to comment

 related articles